PT626385E - Derivados do tetra-hidropirano - Google Patents
Derivados do tetra-hidropiranoInfo
- Publication number
- PT626385E PT626385E PT94810297T PT94810297T PT626385E PT 626385 E PT626385 E PT 626385E PT 94810297 T PT94810297 T PT 94810297T PT 94810297 T PT94810297 T PT 94810297T PT 626385 E PT626385 E PT 626385E
- Authority
- PT
- Portugal
- Prior art keywords
- hydropyrane
- tetra
- derivatives
- hydroxy groups
- antiinflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Color Printing (AREA)
- Seasonings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310969A GB9310969D0 (en) | 1993-05-27 | 1993-05-27 | Organic compounds |
GB939310975A GB9310975D0 (en) | 1993-05-27 | 1993-05-27 | Organic compounds |
GB939312590A GB9312590D0 (en) | 1993-06-18 | 1993-06-18 | Organic compounds |
GB939313553A GB9313553D0 (en) | 1993-07-01 | 1993-07-01 | Organic compounds |
GB939319617A GB9319617D0 (en) | 1993-09-23 | 1993-09-23 | Organic compounds |
GB939319618A GB9319618D0 (en) | 1993-09-23 | 1993-09-23 | Organic compounds |
GB939326045A GB9326045D0 (en) | 1993-12-21 | 1993-12-21 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PT626385E true PT626385E (pt) | 2004-03-31 |
Family
ID=27562893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94810297T PT626385E (pt) | 1993-05-27 | 1994-05-24 | Derivados do tetra-hidropirano |
Country Status (24)
Country | Link |
---|---|
US (1) | US5493019A (pt) |
EP (1) | EP0626385B1 (pt) |
JP (1) | JP3076724B2 (pt) |
CN (1) | CN1048495C (pt) |
AT (1) | ATE252105T1 (pt) |
AU (1) | AU682499B2 (pt) |
CA (1) | CA2124260C (pt) |
CY (1) | CY2523B1 (pt) |
CZ (1) | CZ286157B6 (pt) |
DE (1) | DE69433234T2 (pt) |
DK (1) | DK0626385T3 (pt) |
ES (1) | ES2208651T3 (pt) |
FI (1) | FI107159B (pt) |
HK (1) | HK1011684A1 (pt) |
HU (1) | HU218919B (pt) |
IL (1) | IL109775A (pt) |
MY (1) | MY110603A (pt) |
NO (1) | NO308302B1 (pt) |
NZ (1) | NZ260596A (pt) |
PH (1) | PH30420A (pt) |
PT (1) | PT626385E (pt) |
RU (1) | RU2130460C1 (pt) |
SI (1) | SI0626385T1 (pt) |
SK (1) | SK281541B6 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2308546B (en) | 1994-10-26 | 1999-06-02 | Novartis Ag | Topical macrolide compositions |
JP2001520170A (ja) | 1997-10-16 | 2001-10-30 | ボード・オヴ・リージェンツ,ザ・ユニヴァーシティ・オヴ・テキサス・システム | Nf−at3機能に関連した心肥大動物モデルと治療法 |
TWI235068B (en) | 1998-03-26 | 2005-07-01 | Fujisawa Pharmaceutical Co | Sustained-release pharmaceutical composition |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
US6121257A (en) * | 1999-03-31 | 2000-09-19 | Abbott Laboratories | Sulfamate containing macrocyclic immunomodulators |
US7063857B1 (en) | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
JP2005536516A (ja) | 2002-07-23 | 2005-12-02 | ノバルティス アクチエンゲゼルシャフト | 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物 |
EP1699456A1 (en) * | 2003-12-30 | 2006-09-13 | Astellas Pharma Inc. | Use of macrolides for treating or preventing airflow obstruction |
GT200500282A (es) | 2004-10-12 | 2006-05-04 | Heteroatomos conteniendo compuestos triciclicos. | |
EP1688161A1 (en) * | 2004-11-02 | 2006-08-09 | Switch Biotech Aktiengesellschaft | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
BR112012000750B1 (pt) * | 2009-07-15 | 2021-05-25 | Cti Biopharma Corp. | sal citrato cristalino, composição farmacêutica compreendendo o referido sal e uso do mesmo |
WO2016068208A1 (ja) | 2014-10-28 | 2016-05-06 | 国立研究開発法人国立成育医療研究センター | 妊娠状態を改善するための薬剤及びその利用 |
CN112533599A (zh) | 2018-08-10 | 2021-03-19 | 山口晃史 | 与母体和胎儿的关系中的体液免疫相关的疾病的治疗药 |
JPWO2020129348A1 (ja) | 2018-12-18 | 2021-11-04 | 晃史 山口 | 不妊・不育症または妊娠状態を改善するための薬剤 |
CA3127613A1 (en) * | 2019-01-23 | 2020-07-30 | The Johns Hopkins University | Non-immunosuppressive fk506 analogs and use thereof |
WO2022139524A1 (ko) * | 2020-12-24 | 2022-06-30 | 서울대학교산학협력단 | 신규 fk506 유도체 및 이를 포함하는 발모 촉진용 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0078235A3 (de) * | 1981-10-23 | 1983-06-29 | Ciba-Geigy Ag | Dihalogenierte Steroide |
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
GB2212061B (en) * | 1987-11-09 | 1991-08-28 | Sandoz Ltd | Topical compositions comprising 11,28-dioxa-4-azatricyclo [22.3.1.0(4,9)] octacos-18-ene derivatives |
EP0385936A1 (de) * | 1989-02-27 | 1990-09-05 | Ciba-Geigy Ag | Peptidlacton und derivate davon, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens |
JPH05505798A (ja) * | 1990-03-13 | 1993-08-26 | フアイソンズ・ピーエルシー | 免疫抑制マクロ環状化合物 |
CA2051872A1 (en) * | 1990-09-24 | 1992-03-25 | Kevin M. Byrne | Directed biosynthesis process for prolyl-immunomycin |
GB2249787A (en) * | 1990-11-19 | 1992-05-20 | Fujisawa Pharmaceutical Co | Lactone compounds |
WO1992013862A1 (en) * | 1991-02-05 | 1992-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Lactone compounds |
JP3036923B2 (ja) * | 1991-10-28 | 2000-04-24 | 理化学研究所 | デプシペプチドa、bその製造方法、並びに抗ウイルス剤及び抗菌剤 |
HUT66531A (en) * | 1992-05-07 | 1994-12-28 | Sandoz Ag | Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them |
-
1994
- 1994-05-23 MY MYPI94001314A patent/MY110603A/en unknown
- 1994-05-24 PT PT94810297T patent/PT626385E/pt unknown
- 1994-05-24 EP EP94810297A patent/EP0626385B1/en not_active Expired - Lifetime
- 1994-05-24 PH PH48331A patent/PH30420A/en unknown
- 1994-05-24 ES ES94810297T patent/ES2208651T3/es not_active Expired - Lifetime
- 1994-05-24 SI SI9430457T patent/SI0626385T1/xx unknown
- 1994-05-24 AT AT94810297T patent/ATE252105T1/de not_active IP Right Cessation
- 1994-05-24 DE DE69433234T patent/DE69433234T2/de not_active Expired - Lifetime
- 1994-05-24 DK DK94810297T patent/DK0626385T3/da active
- 1994-05-25 IL IL10977594A patent/IL109775A/xx not_active IP Right Cessation
- 1994-05-25 AU AU63317/94A patent/AU682499B2/en not_active Ceased
- 1994-05-25 CA CA002124260A patent/CA2124260C/en not_active Expired - Fee Related
- 1994-05-25 NZ NZ260596A patent/NZ260596A/en not_active IP Right Cessation
- 1994-05-25 FI FI942444A patent/FI107159B/fi not_active IP Right Cessation
- 1994-05-25 NO NO941936A patent/NO308302B1/no not_active IP Right Cessation
- 1994-05-25 SK SK611-94A patent/SK281541B6/sk not_active IP Right Cessation
- 1994-05-25 HU HU9401582A patent/HU218919B/hu not_active IP Right Cessation
- 1994-05-26 CZ CZ19941295A patent/CZ286157B6/cs not_active IP Right Cessation
- 1994-05-26 US US08/249,911 patent/US5493019A/en not_active Expired - Lifetime
- 1994-05-26 JP JP06112552A patent/JP3076724B2/ja not_active Expired - Fee Related
- 1994-05-26 RU RU94018524A patent/RU2130460C1/ru not_active IP Right Cessation
- 1994-05-26 CN CN94105935A patent/CN1048495C/zh not_active Expired - Fee Related
-
1998
- 1998-12-04 HK HK98112853A patent/HK1011684A1/xx not_active IP Right Cessation
-
2005
- 2005-04-14 CY CY0500023A patent/CY2523B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2523B1 (en) | Tetrahydropyran derivatives | |
PL300068A1 (en) | 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent | |
RU94018524A (ru) | Производные тетрагидропирана, способ их получения и фармацевтическая композиция на их основе | |
AU3839393A (en) | Improvements in or relating to organic compounds | |
GB9409882D0 (en) | Organic compounds | |
AU2704492A (en) | Improvements in or relating to organic compounds |